Thatcher - Serendipity & Chirality Flashcards
1
Q
Phocomelia
A
- Caused by Thalidomide
- Drug thought to be safe for morning sickness during pregnancy
-
Thomas Quasthoff
- German musician with phocomelia
2
Q
Thalidomide History
A
- German company - Grunenthal in 1954
-
Serendipitous Finding
- as an antiemetic –> morning sickness
- Marketed for insomnia/cold/cough/headaches
3
Q
Frances Oldham Kelsey
A
- Richard Merrel demanded Thalidomide FDA approval 6 times
-
Frances DECLINED 6 times
- due to lack of trial data in the USA
- Only 17 children w/ thalidomide induced malformations
- due to lack of trial data in the USA
4
Q
Enantiomers of Thalidomide
A
-
R-Enantiomer was thought to be safe
- but was not exactly true –> can interconvert
-
DOSE DID NOT MATCH CONC IN HUMANS
- was not seen in animals
- higher doses for humans –> led to chiral inversions
-
DOSE DID NOT MATCH CONC IN HUMANS
- but was not exactly true –> can interconvert
-
S-enantiomer
- exerts embryotoxic / teratogenic effect
5
Q
Uses of Thalidomide
A
-
ENL (Erythema nodosum leprosum) - leprasy form
- effective @ improving lesions/fevers/night sweats in patients w/ ENL
-
MULTIPLE MYELOMA
- 1999 found to be effective for advanced/refractory MM
- Outweighs risk of birth defects
6
Q
Thalidomide MOA
A
-
Anti-Inflammatory
-
INHIBITS TNF-alpha
- monocyte derived
-
INHIBITS TNF-alpha
-
Anti-Agiogenic
- inhibits angiogenesis
7
Q
Pomalidomide -> Lenalidomide
A
Druges DERIVED from Pthalidmide
- Used for:
- Antiangiogenic
- Immunomodulatory
8
Q
Apremilast
A
Drug Derived From Pthalimide
Psoriasis
PDE4 inhibitor
Lower TNF-a (antiinflammatory
Immunomodulatory
9
Q
Cereblon
A
Component of the E3 Ubiquitine Ligase (pVHL)
of Thalidomide
- Thalidomide binds to Cereblon
- –> Promotes recruitment of IKZF1 + IKZF3 (ikaros/aiolos)
- –> Substrate ubiquination / degradation
- –> Promotes recruitment of IKZF1 + IKZF3 (ikaros/aiolos)
-
Thought to be the MoA that causes birth defects!
- downregulating cereblon in chicks/fish
- –> defects in embryos
- downregulating cereblon in chicks/fish
10
Q
Thalidomide as a Cancer Agent
A
-
Downregulator/degrader & Protac
- like SERDS (inhibit and degrade estrogen receptors)
-
Cerebolon = ubiquitine ligase
- where pthalimide binds
- LInked with BET ( epigenetic regulator)
-
–> ubiquinates target protein
- –> tells protease to DEGRADE the protein
- basis to tag proteins to degrade them
- why its a target for cancer
-
–> ubiquinates target protein
11
Q
Serendipitious Discovery
of Omeprazole
Timoprazole
A
-
Start AT CMN131
- an antisecretory compound
- but caused liver toxicity (thioamide group)
- an antisecretory compound
-
Added analogs
- –> viewed phenotypic Effects
-
Found Timoprazole
- had anti-secretary affects
12
Q
Serendipitious Discovery
Omeprazole
A
-
From Timoprazole
- we wanted to make it more Anti-Acid
- –> MAKE MORE BASIC
- maximize accumulation of drug within parietal cell
- we wanted to make it more Anti-Acid
-
Added substituants that make the pyridine MOST BASIC
- –> increase the pKA
-
Discovered Omerprazole
- increased thepKa of the pyridine by the most
-
Discovered Omerprazole
- –> increase the pKA
13
Q
Unexpected Mechanism
“rational drug design”
of OMEPRAZOLE
A
-
Omeprazole acts on PPI
- undergoes a BIOACTIVATION process
- sometimes condisdered a prodrug
- Reaarangement generates an ELECTROPHILE
- that reacts with a CYSTEINE in the enzymes
- the proton pump
-
DISULFIDE FORMATION
- not irreversible but is slow
- covalent modification of protein target
- that reacts with a CYSTEINE in the enzymes
- undergoes a BIOACTIVATION process
14
Q
Omeprazole
Mechanism of Action
A
- binds to CYS813 / CYS822 on the PPI pump enzyme
- ATP dependent, sits on membrane
- Helps maintain acidity in the stomach
-
Target is the Cysteine
- most NUCLEOPHILIC functional group
15
Q
Omeprazole
Chirality
A
Omeprazole is a Racemate
- Sulfur = Chiral Center
- S-enantiomer was claimed to have better Bioavailability & onset of action
- True but the S version didnt prove to actually be better than omeprazole.
- The bioavailability & action was already enough to work